Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
The National Trend of the Burden of Chronic Kidney Disease (Ckd) in Iran From 1990 to 2019 Publisher



Khashayar P1, 2 ; Sharifnejad Tehrani Y3 ; Tabatabaeimalazy O3, 4 ; Khashayar P1, 2 ; Saeedi Moghaddam S3, 6 ; Shobeiri P3 ; Golestani A3 ; Esfahani Z3, 7 ; Shokri Varniab Z3 ; Nasserinejad M3, 8 ; Pourabhari Langroudi A3 ; Dilmaghanimarand A9 ; Kazemi A3 ; Rezaei N3, 4 Show All Authors
Authors
  1. Khashayar P1, 2
  2. Sharifnejad Tehrani Y3
  3. Tabatabaeimalazy O3, 4
  4. Khashayar P1, 2
  5. Saeedi Moghaddam S3, 6
  6. Shobeiri P3
  7. Golestani A3
  8. Esfahani Z3, 7
  9. Shokri Varniab Z3
  10. Nasserinejad M3, 8
  11. Pourabhari Langroudi A3
  12. Dilmaghanimarand A9
  13. Kazemi A3
  14. Rezaei N3, 4
  15. Larijani B4
Show Affiliations
Authors Affiliations
  1. 1. Osteoporosis Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Center for Microsystem Technology, Imec and Ghent, University Ghent Belgium, Ghent, Belgium
  3. 3. Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  4. 4. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  5. 5. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom
  6. 6. Kiel Institute for the World Economy, Kiel, Germany
  7. 7. Department of Biostatistics, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran
  8. 8. Center for Life Course Health Research, Faculty of Medicine, University of Oulu, Oulu, Finland
  9. 9. Metabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

Source: Journal of Diabetes and Metabolic Disorders Published:2023


Abstract

Purpose: Chronic Kidney Disease (CKD) has become the 8th leading cause of death in Iran in 2017, 5 steps up from 1990. This is important as hypertension, diabetes, and chronic glomerulonephritis along with exposure to toxins or heavy metals are the main risk factors for the disease. Despite its heavy burden, there are limited studies on the incidence and prevalence of the disease in the Iranian adult population. The present article studies the burden of CKD at the national level in 2019, and its trend over the past three decades. Methods: In 2019, the Global Burden of Disease (GBD) study provided an annual estimation of the burden of 369 diseases and injuries in 204 countries from 1990 until 2019. The data estimating CKD and related mortality in Iran were collected from the disease registry, survey, and scientific literature. All-ages and age-standardised indices of incidence, prevalence, deaths, years lived with disability, years of life lost, and disability-adjusted life years (DALYs) were extracted for both sexes. Results: Since 1990, the age-standardized incidence (34.7% (95% uncertainty interval 30.8 – 38.8)) and prevalence (19.6% (17.7 – 21.8)) of CKD have risen, while a 21.5% (-28.8 – -15.4) and 18.0% (-35.4 – -10.8) decrease were noted in age-standardized DALYs and deaths rates, respectively. The lowest prevalence was reported in the eastern and western provinces. Conclusion: Current study provides comprehensive knowledge about the CKD burden, suggesting the Iranian healthcare system has been more effective in averting deaths rather than managing morbidities. Multi-sectoral action plans are needed to strengthen preventive and early detection programs in high-risk areas. © 2023, The Author(s), under exclusive licence to Tehran University of Medical Sciences.
Other Related Docs
13. Epidemiologic Pattern of Cancers in Iran; Current Knowledge and Future Perspective, Journal of Diabetes and Metabolic Disorders (2021)